Bone Biologics

BBLG
0.39482.66% ( -0.0108 )
Closed: Oct 23, 16:00:01 (EDT)

About

Bone Biologics
Bone Biologics
BBLG.US

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine.

Profile

Company Name
Bone Biologics Corporation
Market
NasdaqCM
Founded
Industry
--
Fiscal Year End
December 31

Related Securities

Industry

Management